Recent advances in ocular drug delivery

Area of Science:

• Ophthalmology
• Pharmaceutical Sciences
• Drug Delivery Systems

Background:

• Conventional ocular drug delivery faces challenges including short drug contact time, rapid elimination, and poor bioavailability due to physiological factors like tear turnover and corneal impermeability.
• The eye's unique anatomy presents significant hurdles for effective ophthalmic drug administration and absorption.
• Improving drug residence time and penetration is crucial for enhancing therapeutic efficacy in ocular treatments.

Purpose of the Study:

• To review and discuss various advanced ocular drug delivery systems designed to overcome the limitations of conventional methods.
• To explore novel formulations such as prodrugs, cyclodextrins, penetration enhancers, polymeric gels, and colloidal systems for ophthalmic applications.
• To highlight the potential of these new systems in improving drug bioavailability and achieving sustained drug release in the eye.

Main Methods:

• Review of recent research on chemical delivery systems (prodrugs, cyclodextrins, penetration enhancers).
• Discussion of advanced ocular dosage forms including polymeric gels, bioadhesive hydrogels, and in-situ forming gels.
• Analysis of colloidal systems like liposomes, niosomes, cubosomes, nanoemulsions, and nanoparticles for ocular drug delivery.
• Consideration of excipients used to enhance viscosity and bioadhesion in ophthalmic formulations.

Main Results:

• Novel ophthalmic delivery systems, particularly colloidal systems and advanced gels, demonstrate potential for sustained drug release.
• In vitro and in vivo studies show increased drug bioavailability with these new formulations compared to conventional methods.
• Combining properties of different pharmaceutical formulations offers synergistic benefits for bioavailability and sustained release.

Conclusions:

• Advanced ocular drug delivery systems, especially colloidal formulations, offer promising solutions for improved patient compliance and prolonged therapeutic effects.
• These innovative systems represent a significant advancement in ophthalmic drug delivery, addressing key challenges in bioavailability and residence time.
• Further research and development in novel ophthalmic delivery systems are essential for creating ideal therapeutic solutions for eye diseases.